echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Nat Commun: Scientists hope to combine nanotechnology with genetic engineering to develop new cancer therapies.

    Nat Commun: Scientists hope to combine nanotechnology with genetic engineering to develop new cancer therapies.

    • Last Update: 2020-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    19, 2020 // -- The development of selective anti-cancer-active chemotherapy drugs is becoming less attractive to scientists due to the emergence of cancer resistance, poor targeting of tumor tissue, and subsequent metastasis of cancer, and in tumor-specific cell types, researchers have found that cancer stem cells are closely related to cancer progression and metastasis in patients, reflecting the ability of cancer stem cells to self-renew and enter the body's circulatory system.
    Photo Source: JAIST In a recent study published in the international journal Nature Communications, scientists from Japan's Institute of Advanced Science and Technology and others combined nanotechnology with genetic engineering called photothermogenetics to develop a regulatory technique for the properties of deadly cancer stem cells, which promotes the effective elimination of cancer in the body.
    researcher Eijiro Miyako says: 'We have developed a photoactive functional nanocarbon complex molecule with a polyethyl glycol (PEG)-modified carbon nano-angle (CNH) composition, and this particular carbon nano-angle carries antibody molecules that can target potential type 2 herbal acid family receptors, a photoactive functional nanocarbon complex molecule or can be used as a targeted cancer chemotherapy agent with high therapeutic potential.
    In fact, nanocomposomes are effectively heated by bio-permeable near-infrared light, and when applied to cancer cells and mouse tumor models, these complexes flow through photothermal induced calcium into targeted cells expressing TRPV2 (TRPV2 is a temperature-reactive membrane protein), thereby increasing cancer cell mortality and effectively regulating stem cell properties in cancer.
    current results may help researchers achieve the perfect combination of nanotechnology and genetic engineering to develop new chemotherapy methods to treat many incurable cancers and control stem cell properties of deadly cancers.
    () Original source: Yu, Y., Yang, X., Reghu, S. et al. Photothermogenetic resedion of cancer stemness by near-infrared-light-activatable nanocomplexes. Nat Commun 11, 4117 (2020). doi:10.1038/s41467-020-17768-3.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.